Weight loss & diabetes: new FDA approvals
Brand, generic name, approval date and the use the FDA approved it for. No recommendations. Updated 2026-10-12.
Weight loss & diabetesCancerBrain & mental healthInfections & vaccinesHeart & bloodImmune & inflammatoryKidney, liver & lungEyeWomen's & hormonal healthPain & anesthesiaDiagnostic & imaging agentsRare & geneticOther
OnswikWeight loss & diabetes
insulin efsitora alfa-gobeTo improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exerciseFoundayoWeight loss & diabetes
orforglipron · Eli Lilly And CoTo reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activityAwiqliWeight loss & diabetes
insulin icodec-abaeTo improve glycemic control in adults with type 2 diabetes mellitusRedemploWeight loss & diabetes
plozasiran · ArrowheadTo reduce triglycerides in adults with familial chylomicronemia syndromeTryngolzaWeight loss & diabetes
olezarsen · Ionis Pharms Inc.To treat familial chylomicronemia syndrome